J&J Q1 profit falls 10 pct. despite higher sales PDF  | Print |  E-mail
Written by Associated Press   
Tuesday, 16 April 2013 08:26

NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson says its first-quarter profit fell by just over 10 percent as increased sales were offset by higher costs for production, marketing and administration.

The maker of Tylenol, prescription drugs and medical devices says it earned $3.5 billion, or $1.22 per share, down 10.6 percent from $3.9 billion, or $1.41 per share, a year earlier.

Excluding litigation and acquisition-related charges totaling $610 million, income would have been $4.1 billion, or $1.44 per share. That beat analysts' forecast by 4 cents per share.

Revenue totaled $17.5 billion, up 8.5 percent from $16.1 billion a year earlier. Analysts expected sales of $17.46 billion.

U.S. sales were up 11.2 percent as the company returned more of its recalled nonprescription drugs to store shelves. International sales grew by 6.3 percent.


Copyright 2013 The Associated Press.

 

Front Page Stories

Perrysburg Twp. Man Sentenced to 22 Years for Rape
07/24/2014 | Sentinel-Tribune Staff

A Perrysburg Township man was senteced to more than 22 years in prison after being found guilty Thur [ ... ]


Vigil set for BGSU student
07/24/2014 | Associated Press

CLEVELAND (AP) — A vigil for a Bowling Green State University student who was found dead in Lorain [ ... ]


Other Front Page Articles